JA Solar Technology Co Ltd (002459)
Shenzhen Stock Exchange · China · prices in CNY · close of 27 Oct 2026
Key indicators
| Last close | CNY 6.590 |
|---|---|
| 52-week range | 6.260 – 15.540 |
| Return, 1 month / 3 months | −1.6% / −8.7% |
| Return, 1 year / 3 years | −49.5% / −70.1% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 44.6% |
| Worst drawdown (1 year) | -58.1% |
| Average daily value traded | 236.07M CNY |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
JA Solar Technology makes solar power products, chiefly monocrystalline silicon cells and photovoltaic modules that turn sunlight into electricity. The company supplies these panels to project developers, installers and utilities that build solar power plants and rooftop systems, and it serves customers in many countries. JA Solar is based in Beijing, China, and its business centres on manufacturing and distributing solar energy equipment for electricity generation.
The shares are listed on the Shenzhen Stock Exchange in China under the code 002459, and the price on this page is in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
JA Solar Technology Co Ltd (002459) trades on the Shenzhen Stock Exchange in China. It last closed at CNY 6.590 on 27 October 2026.
Its price-based Market X-Ray is 29 out of 100 (a weak price profile), ranking 2,536 of 2,822 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 49.5% and over the last three months it fell 8.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shenzhen Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 10 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -30.2% | ||
| From 52-week high | -56.9% | ||
| Momentum | 15 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.7% | ||
| 6-month return | -38.3% | ||
| 12-month return, skipping the last month | -48.6% | ||
| Stability (higher is calmer) | 37 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 44.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -58.1% | ||
| Liquidity | 69 · Fair | Moderate trading activity. | |
| Average daily value traded | 236.07M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +1.7% |
|---|---|
| 1 month | −1.6% |
| 3 months | −8.7% |
| 6 months | −38.3% |
| 1 year | −49.5% |
| 3 years | −70.1% |
| 5 years | −83.5% |
Signals
| 50-day / 200-day average | 6.914 / 9.434 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.222 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 May 2024 | CNY 0.5630 |
| 25 Apr 2023 | CNY 0.2400 |
| 17 Jun 2022 | CNY 0.1500 |
| 23 Jul 2021 | CNY 0.2000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shenzhen Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.